Kwaku Ohene-Frempong, MD Named a 2021 Honorific Award Recipient by the American Society of Hematology
Published on in CHOP News
Kwaku Ohene-Frempong, MD was named a 2021 Honorific Award Recipient by the American Society of Hematology.
Sickle Cell Center News and Updates
1 - 10 of 18
CHOP Gene Therapy Experts Profiled in Philadelphia Magazine
Published on in CHOP News
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
CHOP Expert Featured on NBC News
Published on in CHOP News
Fears of catching Covid-19 in ERs forced many in the throes of pain crises to avoid seeking medical attention. Dr. Kim Smith-Whitley explains the importance of seeking care in a COVID-19 world.
Sickle Cell and Covid-19
Published on in CHOP News
Millions of Americans carry the sickle cell trait, many without knowing it. Could they be at risk for severe Covid-19? Stat News Reports.
CHOP Expert Commentary – Impact of COVID-19 on African American Community
Learn how Kim Smith-Whitley, MD, is fighting to improve the lives of her patients in the wake of COVID-19.
Read moreBreakthrough New Therapies Approved for the Treatment of Sickle Cell Disease
The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.
Read moreCHOP Hematologist Hails Approval of Two New Drugs To Manage Sickle Cell Disease (SCD)
Published on in CHOP in the Media
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
CHOP Volunteers Make Camp Special
Published on in Community Impact Report
CHOP volunteers make camp a reality for many kids with special medical needs. They not only keep them healthy, but they also take part of the activities and enjoy seeing kids being kids.
Sickle Cell Patient Featured on Seeking Solutions with Suzanne
Published on in CHOP News
Born with sickle cell disease, Naomi receives breakthrough treatments and screenings at CHOP to keep her symptoms in check and protect her from strokes.
Enzyme Identified as Possible Novel Drug Target for Sickle Cell Disease, Thalassemia
Published on in CHOP News
Researchers have found a key protein that could become a target for a new treatment for sickle cell disease. In lab tests, blocking the protein reduces sickling that distorts red blood cells.